UBS AM
CLMT icon

UBS AM’s Calumet Specialty Products CLMT Stock Holding History

UBS AM’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
155,584
+25,348
+19% +$852K ﹤0.01% 1550
2026
Q1 		$4.68M Sell
130,236
-12,049
-8% -$312K ﹤0.01% 1583
2025
Q4 		$2.83M Buy
142,285
+2,645
+2% +$50.9K ﹤0.01% 1735
2025
Q3 		$2.55M Sell
139,640
-142,726
-51% -$2.35M ﹤0.01% 1652
2025
Q2 		$4.45M Buy
282,366
+70,140
+33% +$892K ﹤0.01% 1768
2025
Q1 		$2.69M Buy
212,226
+134,132
+172% +$2.11M ﹤0.01% 1854
2024
Q4 		$1.72M Buy
+78,094
New +$1.64M ﹤0.01% 2122

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM's CLMT Position: Q2 2026 in Review

UBS AM increased its Calumet Specialty Products (CLMT) stake by 19% in Q2 2026, buying an estimated $852K and bringing the position to 155,584 shares worth $5.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

UBS AM first reported a position in CLMT in Q4 2024 and has held it in 7 quarters since. 189 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • UBS AM held 155,584 shares of Calumet Specialty Products worth $5.6M as of Q2 2026.
  • UBS AM bought 25,348 Calumet Specialty Products shares in Q2 2026, an estimated $852K.
  • Calumet Specialty Products made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1550 holding.
  • UBS AM first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 7 quarters since.
  • 189 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.